Prediction parameters of left ventricular diastolic dysfunction improvement in patients after acute coronary syndrome

Marija Bjelobrk1,2, Tatjana Miljković1,2, Aleksandra Ilić1,2

  • 1Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.

Acta Clinica Belgica
|August 24, 2022
PubMed

Insights

Comprehensive cardiac rehabilitation (CCR) significantly improves left ventricular diastolic dysfunction (LVDD) in acute coronary syndrome (ACS) patients. Key factors for improvement include CCR participation, E/A ratio, and hemoglobin levels.

Area of Science:

  • Cardiology
  • Cardiovascular Rehabilitation
  • Diabetology

Background:

  • Acute coronary syndrome (ACS) often leads to left ventricular diastolic dysfunction (LVDD).
  • Percutaneous coronary intervention (PCI) is a common treatment for ACS, but residual LVDD can impact patient outcomes.
  • Comprehensive cardiac rehabilitation (CCR) is a multidisciplinary approach to improve cardiovascular health.

Purpose of the Study:

  • To evaluate the effectiveness of CCR in improving LVDD in patients post-ACS treated with PCI.
  • To identify key parameters influencing LVDD improvement following CCR.
  • To develop a predictive model for LVDD improvement in this patient population.

Main Methods:

  • Eighty-five patients post-ACS and PCI were divided into an intervention group (N=56) attending CCR and a control group (N=29).
  • Echocardiography and cardiopulmonary exercise testing (CPET) were performed at baseline and after 12 weeks.
  • Multivariate binary logistic regression was used to identify significant predictors of LVDD improvement.

Main Results:

  • A significant improvement in LVDD was observed in 39.3% of patients in the CCR intervention group, compared to only 3.4% in the control group (p < 0.001).
  • Multivariate analysis identified CCR participation, E/A ratio, and hemoglobin levels as key factors for LVDD improvement.
  • A predictive model for LVDD improvement demonstrated high accuracy (Area=0.9, sensitivity=87.0%, specificity=85.5%).

Conclusions:

  • CCR is an effective non-pharmacological strategy for enhancing LVDD and functional capacity in ACS patients post-PCI.
  • The developed statistical model can aid in predicting clinical benefits of CCR in this patient cohort.
  • Further research may explore optimizing CCR protocols based on identified predictive parameters.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
39